FindMyKOL
Clinical trialNCT06393452CompletedPhase 2Interventional

Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

SponsorPelage Pharmaceuticals, Inc.Enrollment78Androgenetic Alopecia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study is a two part study, designed to validate safety results from the Phase 1 PP405-001 trial while also characterizing longer term safety and PK. Part 1 of the trial is the randomized controlled portion that will focus on safety and PK following 28 days of blinded treatment administration with either PP405 or vehicle control. Part 2 of the trial is an open-label extension that will validate the results of Part 1 with 3 months of treatment administration.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • California Dermatology & Clinical Research Institute

    Encinitas, California, United States

  • Clinical Trials Research Institute

    Thousand Oaks, California, United States

  • Dawes Fretzin Clinical Research Group, Llc

    Indianapolis, Indiana, United States

  • Minnesota Clinical Study Center

    New Brighton, Minnesota, United States

  • Dermresearch

    Austin, Texas, United States

  • Stride Clinical Research Llc

    Sugar Land, Texas, United States

  • Jordan Valley Dermatology Center

    South Jordan, Utah, United States

  • Virginia Clinical Research, Inc.

    Norfolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PP405 0.05% Topical GelPP405 Topical Vehicle Gel
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Jun 2024
Primary completion
16 Jul 2025
Completion
1 Oct 2025
Last update posted
11 Dec 2025
Registered enrollment
78
Registry id
NCT06393452
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.